TTRX - NASDAQ

Turn Therapeutics Inc.

TTRX·NASDAQ

$5.75

-3.1%

HealthcareBiotechnology

Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$171.13M

EPS-0.2300

P/E Ratio-24.98

Earnings Date09/02/2026

ttrx

Net Cash Provided by Financing Activities

Last Annual Value

6.92M

3-Year CAGR

140%

5-Year CAGR

69%

10-Year CAGR

30%

Adjust for Inflation

Turn Therapeutics Inc. Competitors Analysis of Net Cash Provided by Financing Activities

TTRX · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Turn Therapeutics Inc. NASDAQ:TTRX	6.92M	140.1%	N/A	N/A
Tevogen Bio Holdings Inc. NASDAQ:TVGN	12.23M	46.7%	-0.4%	N/A
Greenwich LifeSciences, Inc. NASDAQ:GLSI	12.00M	N/A	33.4%	N/A
Actuate Therapeutics Inc NASDAQ:ACTU	23.72M	79.0%	N/A	N/A
Alto Neuroscience, Inc. NYSE:ANRO	60.08M	-4.1%	13.6%	N/A
C4 Therapeutics, Inc. NASDAQ:CCCC	126.40M	40.6%	-5.9%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	2.58M	N/A	-40.8%	1.2%
Nuvectis Pharma, Inc. NASDAQ:NVCT	29.11M	24.5%	13.8%	N/A
PepGen Inc. NASDAQ:PEPG	107.98M	N/A	-6.1%	N/A
Seer, Inc. NASDAQ:SEER	-10.57M	N/A	N/A	N/A
TuHURA Biosciences, Inc. NASDAQ:HURA	19.93M	95.7%	23.1%	8.9%

Turn Therapeutics Inc. Fair Value Envelope

TTRX · NASDAQ

Our analysis suggests that TTRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.745, this represents a potential HIDDEN relative to our calculated worth for Turn Therapeutics Inc..

HIDDEN

Intrinsic Value

Current Price: $5.745

Related Guides

Blog Categories

Continue your TTRX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.